Sarepta Therapeutics, Inc.

Cambridge,  MA 
United States
  • Booth: 635


Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates and is proud to support the 2018 ACMG Annual Meeting. For more information about Sarepta, please visit